These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15140326)

  • 1. Erectile dysfunction: an underdiagnosed condition associated with multiple risk factors.
    Shabbir M; Mikhailidis DM; Morgan RJ
    Curr Med Res Opin; 2004 May; 20(5):603-6. PubMed ID: 15140326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.
    Yassin A; Saad F; Hoesl CE; Traish AM; Hammadeh M; Shabsigh R
    Andrologia; 2006 Feb; 38(1):1-12. PubMed ID: 16420236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension.
    McVary KT; Kaufman J; Young JM; Tseng LJ
    Int J Clin Pract; 2007 Nov; 61(11):1843-9. PubMed ID: 17887993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The positive effect of sildenafil on LUTS from BPH while treating ED].
    Ying J; Yao D; Jiang Y; Ren X; Xu M
    Zhonghua Nan Ke Xue; 2004 Sep; 10(9):681-3. PubMed ID: 15497711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erectile dysfunction (ED) is prevalent, bothersome and underdiagnosed in patients consulting urologists for benign prostatic syndrome (BPS).
    Hoesl CE; Woll EM; Burkart M; Altwein JE
    Eur Urol; 2005 Apr; 47(4):511-7. PubMed ID: 15774251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney disease quality of life of Japanese dialysis patients who desire administration of sildenafil and the treatment of erectile dysfunction using sildenafil.
    Hyodo T; Ishida H; Masui N; Taira T; Yamamoto S; Oka M; Uchida T; Endo T; Sakai T; Yoshida K; Baba S
    Ther Apher Dial; 2004 Aug; 8(4):340-6. PubMed ID: 15274687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].
    Rosen R; Altwein J; Boyle P; Kirby RS; Lukacs B; Meuleman E; O'Leary MP; Puppo P; Chris R; Giuliano F
    Prog Urol; 2004 Jun; 14(3):332-44. PubMed ID: 15373175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the efficacy and safety of sildenafil citrate in the geriatric population.
    Müller A; Smith L; Parker M; Mulhall JP
    BJU Int; 2007 Jul; 100(1):117-21. PubMed ID: 17552959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.
    Safarinejad MR; Kolahi AA; Ghaedi G
    BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common approach to managing lower urinary tract symptoms and erectile dysfunction.
    Taylor JM; Desouza R; Wang R
    Asian J Androl; 2008 Jan; 10(1):45-53. PubMed ID: 18087643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular safety of PDE5 inhibitors.
    Herschorn S
    Can J Urol; 2003 Feb; 10 Suppl 1():23-8. PubMed ID: 12625847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment.
    Ponholzer A; Madersbacher S
    Int J Impot Res; 2007; 19(6):544-50. PubMed ID: 17611608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile dysfunction: evaluation and new treatment options.
    Carson CC
    Psychosom Med; 2004; 66(5):664-71. PubMed ID: 15385689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-marketing surveillance study of the safety and efficacy of sildenafil prescribed in primary care to erectile dysfunction patients.
    Sunwoo S; Kim YS; Cho BL; Cheon KS; Seo HG; Rho MK; Cheong YS; Hong MH; Kim SW; Kim DH;
    Int J Impot Res; 2005; 17(1):71-5. PubMed ID: 15510193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction].
    Shen ZJ; Yu YL
    Zhonghua Nan Ke Xue; 2005 Aug; 11(8):631-4. PubMed ID: 16138588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the 'Cottbus Survey' with 10 000 men.
    May M; Gralla O; Knoll N; Fenske S; Spivak I; Rönnebeck C; Hoffmann M; Lenk S; Hoschke B
    BJU Int; 2007 Nov; 100(5):1110-5. PubMed ID: 17922788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
    Doggrell S
    Int J Impot Res; 2007; 19(3):281-95. PubMed ID: 17183346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.